Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences have made an important advancement in the field of single-cell transcriptomics by developing a novel bead design that reduces errors in DNA synthesis and improves the reliability of gene expression measurements.

DNA strand

Single-cell transcriptomics has revolutionised the study of cellular diversity and function by enabling gene expression analysis at single-cell resolution. The technique is crucial for understanding how different cells function, how they communicate, and how they contribute to various biological processes and diseases.

However, technical errors in the synthesis of oligonucleotides (short DNA sequences)—particularly in droplet-based methods such as Drop-seq and 10x Chromium—frequently lead to inaccurate results, causing researchers to discard valuable data. These synthesis errors obscure identification of the cell barcode (which identifies the cell) and UMI (unique molecular identifier) resulting in substantial data loss and limiting sequencing efficiency.

Published in Communications Biology, Associate Professor Adam Cribbs and Dr. Jianfeng Sun at the Botnar Institute for Musculoskeletal Sciences identified a major source of error: premature truncation of UMIs before sequencing.  To address this, they developed a novel bead design that improves the reliability of gene expression measurements by mitigating truncation errors in UMIs prior to sequencing.

They added what they call an “anchor” between two important parts of the sequence: between the barcode and UMI. This anchor provides a clear demarcation point, enhancing UMI recognition and minimising synthesis errors.

The work builds on the Oxford team’s previous homotrimer UMI error correction strategy, which focused on errors arising after sequencing. In contrast, the new anchor-interposed approach tackles UMI errors at the pre-sequencing stage, further advancing long-read transcriptomics. 

 

Read the full story on the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences website.

 

 

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience